The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01M | Quinolone antibacterials | |
4
|
J01MA | Fluoroquinolones | |
5
|
J01MA23 |
| Active Ingredient |
|---|
|
Delafloxacin inhibits bacterial topoisomerase IV and DNA gyrase (topoisomerase II), enzymes required for bacterial DNA replication, transcription, repair, and recombination. |
| Document | Type | Information Source | |
|---|---|---|---|
| QUOFENIX Powder for concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| QUOFENIX Tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.